Actinium Pharmaceuticals Inc. (Delaware) (ATNM) dipped -5.43% or -0.02 to $0.27. It is near to 1.36 million shares traded, which is 78.89% compare to the average total volume 1.73 million. The market cap of ATNM is $32.19 million. The year to date change is -39.94%. The 52 week price range is from $0.26 to $0.87. Price of ATNM have changed -1.86% during last week. It have changed -49.20% over last month, -45.95% over last 3 months, -47.92% over last 6 months and -20.64% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ATNM is 0.47. It is 74.07% above current price. The 200-day Moving Averages for ATNM is 0.56. It is 107.41% above current price. The 52-week High is 0.87. It is 222.22% from the current price. The 52-week Low is 0.26. It is -3.70% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ATNM is 3.93 on 2019-04-15. Short % to float is 2.43%. There are some statistics of ATNM. It is has market cap $32.19 million. The share outstanding is 119.14 million. The average volume is 1.73 million. The percent of top 15 Institution holding is 11.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ATNM is -216.02%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ATNM is -145.82%.